Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $5.30 and last traded at $5.30, with a volume of 110 shares trading hands. The stock had previously closed at $4.92.
Oxford Biomedica Trading Up 7.7 %
The stock has a 50 day moving average price of $4.66 and a 200-day moving average price of $4.13. The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35.
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
- Five stocks we like better than Oxford Biomedica
- How Investors Can Find the Best Cheap Dividend Stocks
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- The How And Why of Investing in Oil Stocks
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
